Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1

Conditions

Hypoxia 3Uterine Cervical Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Neoplasm Metastasis 1

Interventions

fluoroazomycin arabinoside 33-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 3pimonidazole 2Propofol 2Blood Specimen Collection 2gadobutrol 1Sevoflurane 1Radiotherapy 1Pancreaticoduodenectomy 1Oxygen 1Ketamine 1Gemcitabine 1Furosemide 1Exercise 1Diagnostic Imaging 1Biopsy 14-methylbenzenesulfonic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Hypoxia × fluoroazomycin arabinoside × Clear all
NCT03418818 2026-03-06

FAZA PET/MRI Sarcoma

University Health Network, Toronto

Phase NA Active not recruiting
70 enrolled
Sarcoma

Hypoxia, Sarcoma

NCT04395469 2026-03-05

FAZA PET/MRI Pancreas

University Health Network, Toronto

Phase NA Active not recruiting
20 enrolled

Hypoxia

NCT02496832 2018-02-19

A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo

University Health Network, Toronto

Phase NA Withdrawn

Hypoxia, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡